Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| 1 |
Bristol-Myers Squibb
BMY
|
$766M |
| 2 |
Adobe
ADBE
|
$529M |
| 3 |
Merck
MRK
|
$463M |
| 4 |
Tesla
TSLA
|
$359M |
| 5 |
AGN
Allergan plc
AGN
|
$339M |
Top Sells
| 1 |
UnitedHealth
UNH
|
$714M |
| 2 |
Gilead Sciences
GILD
|
$600M |
| 3 |
Perrigo
PRGO
|
$585M |
| 4 |
EMC
EMC CORPORATION
EMC
|
$448M |
| 5 |
Morgan Stanley
MS
|
$423M |
Sector Composition
| 1 | Healthcare | 17.95% |
| 2 | Consumer Discretionary | 15% |
| 3 | Communication Services | 10.58% |
| 4 | Technology | 9.94% |
| 5 | Financials | 9.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
501
Essential Utilities
WTRG
$11B
| $5.29M | 0.01% |
224,016
-704,969
| -76% | -$16.6M |
|
|
STAY
502
DELISTED
Extended Stay America, Inc. Paired Share Unit
STAY
| $5.08M | 0.01% |
+193,387
| New | +$5.08M |
|
|
AENZ
503
DELISTED
Aenza S.A.A. American Depositary Shares (each representing fifteen (15) Common Shares)
AENZ
| $4.89M | ﹤0.01% |
76,824
| – | – |
|
|
BRLI
504
DELISTED
BIO-REFERENCE LABS INC-NEW-
BRLI
| $4.65M | ﹤0.01% |
181,970
-1,682,153
| -90% | -$43M |
|
|
TEN
505
DELISTED
Tenneco Inc. Class A Voting Common Stock
TEN
| $4.64M | ﹤0.01% |
82,068
-34
| -0% | -$1.92K |
|
|
AERI
506
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $4.61M | ﹤0.01% |
+256,864
| New | +$4.61M |
|
507
IQVIA
IQV
$31.9B
| $4.59M | ﹤0.01% |
99,145
-502,607
| -84% | -$23.3M |
|
|
TRNX
508
DELISTED
TORNIER N V SHARES (NLD)
TRNX
| $4.47M | ﹤0.01% |
237,943
+894
| +0.4% | +$16.8K |
|
509
InspireMD
NSPR
$101M
| – | – |
0
| – | -$4.08M |
|
|
MGLN
510
DELISTED
Magellan Health Services, Inc.
MGLN
| $4.02M | ﹤0.01% |
67,087
-7,315
| -10% | -$438K |
|
|
SUSQ
511
DELISTED
SUSQUEHANNA BANCSHARES INC
SUSQ
| $3.73M | ﹤0.01% |
290,709
+50,186
| +21% | +$644K |
|
512
CSX Corp
CSX
$60.6B
| $3.62M | ﹤0.01% |
377,796
+25,695
| +7% | +$246K |
|
513
Webster Financial
WBS
$10.3B
| $3.61M | ﹤0.01% |
115,841
+22,793
| +24% | +$711K |
|
514
DuPont de Nemours
DD
$32.6B
| $3.55M | ﹤0.01% |
39,630
-872
| -2% | -$78.1K |
|
515
Altria Group
MO
$112B
| $3.52M | ﹤0.01% |
+91,581
| New | +$3.52M |
|
516
Eli Lilly
LLY
$652B
| $3.49M | ﹤0.01% |
68,383
+6,147
| +10% | +$314K |
|
517
Meritage Homes
MTH
$5.89B
| $3.48M | ﹤0.01% |
144,978
+17,944
| +14% | +$431K |
|
518
Macy's
M
$4.64B
| $3.44M | ﹤0.01% |
64,479
+1,323
| +2% | +$70.6K |
|
519
Norfolk Southern
NSC
$62.3B
| $3.42M | ﹤0.01% |
36,812
+9,622
| +35% | +$893K |
|
520
Rogers Corp
ROG
$1.43B
| $3.39M | ﹤0.01% |
55,040
-6,750
| -11% | -$415K |
|
|
CB
521
DELISTED
CHUBB CORPORATION
CB
| $3.35M | ﹤0.01% |
34,668
-894
| -3% | -$86.4K |
|
522
Chevron
CVX
$310B
| $3.33M | ﹤0.01% |
26,630
-686
| -3% | -$85.7K |
|
|
SDRL
523
DELISTED
Seadrill Limited Common Stock
SDRL
| $3.31M | ﹤0.01% |
301
+173
| +135% | +$1.9M |
|
524
Archer Daniels Midland
ADM
$30.2B
| $3.3M | ﹤0.01% |
76,070
-12,622
| -14% | -$548K |
|
525
DexCom
DXCM
$31.6B
| $3.25M | ﹤0.01% |
366,960
-56,772
| -13% | -$503K |
|